Clinical Trial Update: SGLT2 for Heart Failure in CHD Patients

View source ↗

Summary

A clinical trial is recruiting to evaluate an SGLT2 inhibitor for heart failure in patients with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Failure

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Heart Failure | Status: RECRUITING